Insider Tracker SEC Form 4 insider trades
← All clusters
OTLK

Outlook Therapeutics, Inc.

Healthcare Biological Products, (No Diagnostic Substances) Market cap: $120.0M All insider activity → Quote and statistics → Sign in to watch OTLK Sign in to set a price alert
76
Insider Score Band 60–79

Research score, not a recommendation.

Total bought$20.2M8 Form 4 purchases
Distinct insiders6open-market buyers
Lead insiderTRENARY C RUSSELL IIICEO
Cluster window2021-11-29 → 2021-12-06closed

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
100%
Seniority executive rank of buyers (CEO/CFO/Director)
84%
Commitment purchase size relative to company & holdings
97%
Context buying into stock weakness signals conviction
100%
Timing coordinated purchases within a tight window
99%
Routine-purchase discount × 1.00
Company-type / offering discount × 1.00
Net insider selling penalty − 0

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

8 Form 4 trades · 6 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Filing
2021-11-29 Sukhtian Ghiath M. history of Sukhtian Ghiath M.'s purchases Director 16,000,000 $1.25 $20.0M SEC filing for Sukhtian Ghiath M. (opens in a new tab)
2021-12-03 → 2021-12-06 Dagnon Terry 3 purchases with a 63-day result · median +37.7% COO 35,201 $1.39 avg $49.0K
2021-12-03 Dagnon Terry 10,000 $1.42 $14.2K SEC filing for Dagnon Terry (opens in a new tab)
2021-12-06 Dagnon Terry 25,201 $1.38 $34.8K SEC filing for Dagnon Terry (opens in a new tab)
2021-12-02 → 2021-12-06 TRENARY C RUSSELL III 3 purchases with a 63-day result · median +37.7% CEO 35,000 $1.39 avg $48.8K
2021-12-02 TRENARY C RUSSELL III 10,000 $1.40 $14.0K SEC filing for TRENARY C RUSSELL III (opens in a new tab)
2021-12-06 TRENARY C RUSSELL III 25,000 $1.39 $34.8K SEC filing for TRENARY C RUSSELL III (opens in a new tab)
2021-12-03 Evanson Jeff history of Evanson Jeff's purchases Other C-suite 35,200 $1.34 $47.2K SEC filing for Evanson Jeff (opens in a new tab)
2021-12-02 Sukhtian Faisal Ghiath 5 purchases with a 63-day result · median +30.2% Director 18,000 $1.40 $25.2K SEC filing for Sukhtian Faisal Ghiath (opens in a new tab)
2021-12-02 Haddadin Yezan Munther 7 purchases with a 63-day result · median -5.0% Director 10,000 $1.39 $13.9K SEC filing for Haddadin Yezan Munther (opens in a new tab)
Total $20.2M

Other buying runs at OTLK

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -4.6%63 days +41.4%126 days -19.0%

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days63 days126 days Status
2026-05-26 → 2026-06-02 5 $5.3M 67 +156.9%-5.0%– active
2022-09-29 → 2022-10-07 3 $334.7K 47 -26.5%-10.4%-18.9% closed
2021-04-19 → 2021-04-20 3 $54.7K 52 +23.1%+30.2%+6.5% closed
2020-09-14 → 2020-09-22 3 $20.1K 41 -3.4%+85.1%+179.7% closed
2018-12-21 → 2019-02-07 4 $136.1K 49 +61.6%-78.2%-62.2% closed